Home/Hedge Fund Intelligence/Design Therapeutics, Inc.
Nasdaq: DSGNStockForm 13F30 Jun 2026

Hedge funds that hold Design Therapeutics, Inc. Nasdaq: DSGN

CUSIP 25056L103 · who reports it, how much, and how much it matters to them

19 of the 720 hedge fund managers we track reported shares of Design Therapeutics, Inc. (Nasdaq: DSGN) on Form 13F for 30 June 2026. Between them they reported USD 170m. The largest position belongs to Logos Global Management, at USD 43m. The manager with the most riding on it is Almitas Capital, where it is 3.6% of the reported book.

Managers reporting it19of 720 we track
Value they reportUSD 170mshares only, 30 Jun 2026
Funds they run182with a file on PPLI.com
Largest positionUSD 43mLogos Global Management
Typical weight0.0%median share of a manager's book
Heaviest weight3.6%Almitas Capital

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

19 managers, USD 170m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Design Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Logos Global Management1 fund on PPLI.comUSD 43m1.9%
2Baker Bros. Advisors2 funds on PPLI.comUSD 39m0.2%
3POINT72 Asset Management17 funds on PPLI.comUSD 34m0.0%
4Almitas Capital2 funds on PPLI.comUSD 15m3.6%
5Sofinnova Investments1 fund on PPLI.comUSD 13m0.6%
6Renaissance Technologies13 funds on PPLI.comUSD 5.6m0.0%
7Acuta Capital Partners2 funds on PPLI.comUSD 4.1m2.8%
8D. E. Shaw & Co.15 funds on PPLI.comUSD 2.8m0.0%
9Eversept Partners3 funds on PPLI.comUSD 2.7m0.1%
10J. Goldman & Co.1 fund on PPLI.comUSD 2.6m0.1%
11Millennium Management6 funds on PPLI.comUSD 2.1m0.0%
12Balyasny Asset Management25 funds on PPLI.comUSD 1.6m0.0%
13Dafna Capital Management6 funds on PPLI.comUSD 1.5m0.3%
14Citadel Advisors32 funds on PPLI.comUSD 1.2m0.0%
15Verdad Advisers6 funds on PPLI.comUSD 688,0000.7%
16Exoduspoint Capital Management7 funds on PPLI.comUSD 597,0000.0%
17Two Sigma Investments35 funds on PPLI.comUSD 476,0000.0%
18Squarepoint Ops7 funds on PPLI.comUSD 429,0000.0%
19The Quarry1 fund on PPLI.comUSD 4490.0%
Next: where it matters most
Where it matters most

For Almitas Capital it is 3.6% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Almitas CapitalUSD 15m3.6%
2Acuta Capital PartnersUSD 4.1m2.8%
3Logos Global ManagementUSD 43m1.9%
4Verdad AdvisersUSD 688,0000.7%
5Sofinnova InvestmentsUSD 13m0.6%
6Dafna Capital ManagementUSD 1.5m0.3%
7Baker Bros. AdvisorsUSD 39m0.2%
8Eversept PartnersUSD 2.7m0.1%
9J. Goldman & Co.USD 2.6m0.1%
10POINT72 Asset ManagementUSD 34m0.0%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Design Therapeutics, Inc.

What is the ticker symbol of Design Therapeutics, Inc.?

Design Therapeutics, Inc. trades under the symbol DSGN on the Nasdaq. Its CUSIP, the code used on Form 13F, is 25056L103.

Which hedge funds own Design Therapeutics, Inc. (Nasdaq: DSGN)?

19 of the 720 hedge fund managers PPLI.com tracks reported Design Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Logos Global Management (USD 43m), Baker Bros. Advisors (USD 39m), POINT72 Asset Management (USD 34m), Almitas Capital (USD 15m) and Sofinnova Investments (USD 13m).

How many hedge funds hold Design Therapeutics, Inc.?

19 managers in our coverage reported it, and between them they run 182 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Design Therapeutics, Inc.?

Almitas Capital, where the position was 3.6% of the reported 13F book at 30 June 2026.

Does this show who is short Design Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Design Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.